SUPERNUS PHARMACEUTICALS, INC. [SUPN] - Supernus Pharmaceuticals / Indivior Pharmaceuticals merger

Under the definitive merger agreement, Indivior stockholders will own approximately 56.5% and Supernus stockholders will own approximately 43.5% of the combined company on a fully diluted basis following the merger.

View source filing ↗